Tirzepatide (LY3298176) is a Dual GIP and GLP-1 Receptor Agonist for Type 2 Diabetes Research
Type 2 Diabetes Mellitus (T2DM) is one of the most common metabolic disorders worldwide. Furthermore, cardiovascular disease (CVD) is the leading cause of morbidity and mortality among patients with T2DM.…